Interferon alpha eye drops: treatment of atypical lymphoid hyperplasia with secondary alopecia.
作者信息
Finger P T, Reichstein D
出版信息
Br J Ophthalmol. 2007 Aug;91(8):1085-6. doi: 10.1136/bjo.2006.106930.
Abstract
摘要
相似文献
1
Interferon alpha eye drops: treatment of atypical lymphoid hyperplasia with secondary alopecia.
Br J Ophthalmol. 2007 Aug;91(8):1085-6. doi: 10.1136/bjo.2006.106930.
2
Drops for corneal neovascularization.
Ophthalmology. 2010 Oct;117(10):2042; author reply 2042-3. doi: 10.1016/j.ophtha.2010.06.011.
3
Intralesional interferon-α for the treatment of bilateral conjunctival mucosa-associated lymphoid tissue lymphoma.
Pediatr Blood Cancer. 2012 Jul 15;59(1):176-8. doi: 10.1002/pbc.23224. Epub 2011 Jul 25.
4
GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial.
Ophthalmology. 2009 Sep;116(9):1630-7. doi: 10.1016/j.ophtha.2009.04.016. Epub 2009 Jul 29.
5
Interferon alpha-2b in giant ocular surface squamous neoplasia.
Indian J Ophthalmol. 2016 May;64(5):393-4. doi: 10.4103/0301-4738.185620.
6
[Vitiligo and alopecia in patients with chronic hepatitis C treated with alpha interferon associated or not with ribavirin].
Gastroenterol Hepatol. 2000 Aug-Sep;23(7):362-3.
7
Topical mitomycin C for the treatment of conjunctival tumor.
Ophthalmologica. 2007;221(1):14-7. doi: 10.1159/000096516.
8
[Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
Klin Monbl Augenheilkd. 2001 Jun;218(6):429-34. doi: 10.1055/s-2001-16257.
9
[Be aware of toxicity of eye drops to ocular surface].
Zhonghua Yan Ke Za Zhi. 2005 May;41(5):387-9.
10
[New uses of urea in ophthalmology].
Klin Oczna. 1984 May;86(5):217-9.
引用本文的文献
1
Conjunctival lymphoid hyperplasia treated with topical tacrolimus: A report of two cases.
Am J Ophthalmol Case Rep. 2025 Jan 17;37:102256. doi: 10.1016/j.ajoc.2025.102256. eCollection 2025 Mar.
2
Bilateral benign reactive lymphoid hyperplasia of the conjunctiva: a case treated with oral doxycycline and review of the literature.
Eye Vis (Lond). 2019 Sep 2;6:26. doi: 10.1186/s40662-019-0151-4. eCollection 2019.
3
[Complications in the treatment of ocular surface squamous neoplasia with interferon α‑2b in rheumatoid arthritis].
Ophthalmologe. 2017 Feb;114(2):155-158. doi: 10.1007/s00347-016-0292-y.
本文引用的文献
1
Topical mitomycin chemotherapy for malignant conjunctival and corneal neoplasia.
Br J Ophthalmol. 2006 Jul;90(7):807-9. doi: 10.1136/bjo.2006.092734.
2
Treatment of biopsy proved conjunctival intraepithelial neoplasia with topical interferon alfa-2b.
Br J Ophthalmol. 2005 Sep;89(9):1221. doi: 10.1136/bjo.2004.063339.
3
Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis C.
J Chemother. 2005 Apr;17(2):212-4. doi: 10.1179/joc.2005.17.2.212.
4
Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
Ophthalmology. 2004 Sep;111(9):1755-61. doi: 10.1016/j.ophtha.2004.01.034.
5
A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma.
Dermatology. 2004;208(1):49-54. doi: 10.1159/000075046.
6
Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases.
Graefes Arch Clin Exp Ophthalmol. 2004 Feb;242(2):130-145. doi: 10.1007/s00417-003-0831-5. Epub 2003 Dec 18.
7
Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
Cornea. 2002 Jan;21(1):6-11. doi: 10.1097/00003226-200201000-00003.
8
Chemotherapy for eye cancer.
Surv Ophthalmol. 2001 Mar-Apr;45(5):416-44. doi: 10.1016/s0039-6257(00)00210-1.
9
Prognosis of orbital lymphoid hyperplasia.
Graefes Arch Clin Exp Ophthalmol. 1996 Mar;234(3):150-4. doi: 10.1007/BF00462026.
10
Periocular lymphoproliferative diseases: natural history, prognostic factors, and treatment.
Radiology. 1992 Oct;185(1):63-70. doi: 10.1148/radiology.185.1.1523336.
Zotero 插件